Burning Rock Biotech Ltd SEC filings BNR
Burning Rock Biotech Ltd has 169 filings in SEC EDGAR's recent list, going back to Nov 4, 2019. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Sep 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 9, 2026 | Jun 9, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 28, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 13, 2026 | Mar 12, 2026 |
| 6-K | Current report (foreign issuer) | Dec 23, 2025 | Dec 23, 2025 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Nov 20, 2025 |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Sep 8, 2025 |
| 6-K | Current report (foreign issuer) | Jun 6, 2025 | Jun 6, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 25, 2025 | Mar 25, 2025 |
| 6-K | Current report (foreign issuer) | Dec 31, 2024 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 3, 2024 | Dec 3, 2024 |
| UPLOAD | Letter from the SEC | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| 20-F/A | Amended annual report (foreign issuer) | Nov 26, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Oct 31, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 27, 2024 | Sep 27, 2024 |
| 6-K | Current report (foreign issuer) | Sep 20, 2024 | Sep 20, 2024 |
| 424B3 | Prospectus | Sep 18, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 6, 2024 | Sep 6, 2024 |
| 6-K | Current report (foreign issuer) | Aug 23, 2024 | Aug 23, 2024 |
| 6-K | Current report (foreign issuer) | Aug 19, 2024 | Aug 19, 2024 |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | Jun 3, 2024 |
| 6-K | Current report (foreign issuer) | May 29, 2024 | May 29, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2024 | Dec 31, 2023 |
| F-6 POS | Filing | Apr 26, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 26, 2024 | Apr 26, 2024 |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 6-K | Current report (foreign issuer) | Jan 4, 2024 | Jan 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Current report (foreign issuer) | Nov 30, 2023 | Nov 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 22, 2023 | Nov 22, 2023 |
| UPLOAD | Letter from the SEC | Oct 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 5, 2023 | Aug 31, 2023 |
| CORRESP | Letter to the SEC | Aug 30, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 28, 2023 | Jun 28, 2023 |
| 6-K | Current report (foreign issuer) | May 30, 2023 | May 30, 2023 |
| 6-K | Current report (foreign issuer) | Apr 20, 2023 | Apr 20, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 20, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 28, 2023 | Mar 28, 2023 |
| 6-K | Current report (foreign issuer) | Jan 18, 2023 | Jan 18, 2023 |
| 6-K | Current report (foreign issuer) | Jan 4, 2023 | Jan 4, 2023 |
| 6-K | Current report (foreign issuer) | Nov 16, 2022 | Nov 16, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 424B5 | Prospectus supplement | Nov 7, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Nov 2, 2022 |
| F-6 POS | Filing | Oct 31, 2022 | — |
| 6-K | Current report (foreign issuer) | Oct 27, 2022 | Oct 27, 2022 |
| 6-K | Current report (foreign issuer) | Oct 21, 2022 | Oct 21, 2022 |
| EFFECT | Filing | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| F-3/A | Amendment no. 5 to form f-3 | Sep 28, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| F-3/A | Amendment no. 4 to form f-3 | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| F-3/A | Amendment no. 3 to form f-3 | Sep 12, 2022 | — |
| 6-K | Current report (foreign issuer) | Sep 8, 2022 | Sep 8, 2022 |
| CORRESP | Letter to the SEC | Sep 6, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 31, 2022 | Aug 31, 2022 |
| UPLOAD | Letter from the SEC | Aug 30, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2022 | — |
| CORRESP | Letter to the SEC | Aug 16, 2022 | — |
| F-3/A | Amendment no.2 to form f-3 | Aug 16, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 3, 2022 | Aug 3, 2022 |
| 6-K | Current report (foreign issuer) | Jul 15, 2022 | Jul 15, 2022 |
| UPLOAD | Letter from the SEC | Jul 14, 2022 | — |
| 6-K | Current report (foreign issuer) | Jun 24, 2022 | Jun 24, 2022 |
| 6-K | Current report (foreign issuer) | Jun 21, 2022 | Jun 21, 2022 |
| 6-K | Current report (foreign issuer) | Jun 21, 2022 | Jun 21, 2022 |
| CORRESP | Letter to the SEC | Jun 21, 2022 | — |
| F-3/A | Amendment no.1 to form f-3 | Jun 21, 2022 | — |
| 6-K | Current report (foreign issuer) | May 31, 2022 | May 31, 2022 |
| UPLOAD | Letter from the SEC | May 16, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 29, 2022 | — |
| 20-F | Annual report (foreign issuer) | Apr 29, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 22, 2022 | Mar 22, 2022 |
| 6-K | Current report (foreign issuer) | Dec 29, 2021 | Dec 29, 2021 |
| 6-K | Current report (foreign issuer) | Nov 16, 2021 | Nov 16, 2021 |
| 6-K | Current report (foreign issuer) | Aug 31, 2021 | Aug 31, 2021 |
| 6-K | Current report (foreign issuer) | May 25, 2021 | May 25, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 23, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 11, 2021 | Mar 11, 2021 |
| S-8 | Employee stock plan registration | Dec 8, 2020 | — |
| 424B4 | Prospectus | Dec 4, 2020 | — |
| EFFECT | Filing | Dec 3, 2020 | — |
| F-1MEF | Filing | Dec 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| F-1/A | Amendment no.1 to form f-1 | Dec 2, 2020 | — |
| 6-K | Current report (foreign issuer) | Dec 2, 2020 | Dec 2, 2020 |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Dec 1, 2020 | — |
| 6-K | Current report (foreign issuer) | Nov 20, 2020 | Nov 20, 2020 |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| DRSLTR | Filing | Nov 13, 2020 | — |
| DRS | Filing | Nov 13, 2020 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2020 | Aug 11, 2020 |
| UPLOAD | Letter from the SEC | Jun 16, 2020 | — |
| 424B4 | Prospectus | Jun 12, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| CERT | Filing | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| CORRESP | Letter to the SEC | Jun 10, 2020 | — |
| F-1/A | Amendment no.2 to form f-1 | Jun 8, 2020 | — |
| FWP | Free writing prospectus | Jun 8, 2020 | — |
| 8-A12B | Form 8-a | Jun 5, 2020 | — |
| CORRESP | Letter to the SEC | Jun 5, 2020 | — |
| F-1/A | Amendment no.1 to form f-1 | Jun 5, 2020 | — |
| F-6 | Filing | Jun 3, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| F-1 | Registration statement (foreign issuer) | May 22, 2020 | — |
| DRSLTR | Filing | Feb 18, 2020 | — |
| DRS/A | Filing | Feb 18, 2020 | — |
| DRSLTR | Filing | Jan 10, 2020 | — |
| DRS/A | Filing | Jan 10, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2019 | — |
| DRS/A | Filing | Dec 9, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2019 | — |
| DRSLTR | Filing | Nov 4, 2019 | — |
| DRS | Filing | Nov 4, 2019 | — |
Showing 132 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BNR (Nasdaq)
- Headquarters
- Guangzhou, Guangdong
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1792267
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.